Cosmos Health Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K covers events occurring on September 30, 2025, specifically the Company's 2025 Annual Meeting of Stockholders. Cosmos Health Inc. is incorporated in Nevada and trades on the Nasdaq Capital Market under the symbol COSM.
Key Financial Metrics
This filing is a corporate governance report and does not provide financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity metrics. No financial statements are included in this document.
Material Changes and Corporate Actions
The following material actions were approved by stockholders at the Annual Meeting:
- Director Elections: Six directors were elected to serve until the next Annual Meeting: Grigorios Siokas, Demetrios G. Demetriades, John J. Hoidas, Dr. Anastasios Aslidis, Suhel Bhutawala, and Theodoros C. Karkantzos.
- Capital Structure Amendment: Stockholders approved an amendment to the Articles of Incorporation to increase authorized shares to 1,500,000,000 shares of Common Stock and 300,000,000 shares of "blank check" Preferred Stock.
- Reverse Stock Split Authorization: The Board was authorized to amend the Articles of Incorporation to effect a reverse stock split at their discretion.
- Equity and Note Issuance: Stockholders approved the issuance of shares upon conversion of notes to comply with Nasdaq Listing Rule 5635(d) and approved the 2025 Equity Omnibus Plan.
- Accounting Firm Ratification: The appointment of the Independent Registered Public Accounting Firm was ratified.
Voting Results and Management Commentary
Of the 30,127,379 shares outstanding on the record date, 15,983,371 shares (approximately 53%) were present or represented by proxy. All proposals submitted to the vote passed.
- Director Support: Votes for directors ranged from approximately 12.0 million to 13.8 million, with votes withheld ranging from 2.2 million to 3.9 million.
- Reverse Stock Split: Received 13,898,821 votes for and 2,084,235 votes against.
- Authorized Share Increase: Received 13,802,295 votes for and 2,176,907 votes against.
- Say on Pay Frequency: Stockholders voted to hold future "Say on Pay" votes every three years (13,082,602 votes) rather than annually (2,658,606 votes).
The filing does not contain specific management commentary on future outlook, risks, or contingencies beyond the standard disclosures regarding the effectiveness of the amendment upon filing with the State of Nevada.
Investor Verification Checklist
- Verify the effective date of the Articles of Incorporation amendment with the Nevada Secretary of State.
- Review the definitive proxy statement filed on August 22, 2025, for detailed terms of the reverse stock split and the 2025 Equity Omnibus Plan.
- Monitor future filings for the execution of the reverse stock split, as the Board retains discretion on timing and ratio.
- Check subsequent 10-Q or 10-K filings for the financial impact of the note conversions approved under Proposal 3.